The ethical issues of the postmarketing surveillance of drug teratogenicity in Hungary

Pharmacoepidemiology and Drug Safety

Volumn 10, Issue 7, 2001, Pages 635-639

  Czeizel, Andrew E ^a  

^a FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

Author keywords

Confidential handling of data and informed consent; Drug teratogenicity; Personal data protection; Postmarketing surveillance

Indexed keywords

TERATOGENIC AGENT;

ADULT; ARTICLE; AUTOPSY; CHILD DEATH; CONFIDENTIALITY; CONGENITAL DISORDER; CONTROLLED STUDY; DOWN SYNDROME; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH CARE; HUMAN; HUMAN RIGHTS; HUNGARY; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MEDICAL ETHICS; NEWBORN; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLICATION; TERATOGENICITY;

BIOETHICS; CONFIDENTIALITY; HUMANS; HUNGARY; INFORMED CONSENT; PHARMACOEPIDEMIOLOGY; PRODUCT SURVEILLANCE, POSTMARKETING; PUBLIC HEALTH; PUBLICATION BIAS; RESEARCH; TERATOGENS;

EID: 0035571626     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.635     Document Type: Article

References (10)

1. First 25 years of the Hungarian Congenital Abnormality Registry
2. An aetiological evaluation of increased occurrence of congenital limb reduction abnormalities in Hungary, 1975-1978
3. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996
4. The role of pharmacoepidemiology in pharmacovigilance: Rational drug use in pregnancy
5. Drugs and the fetus
6. The Hungarian Periconception Service as a model for community genetics
7. Analysis of medical indications for induced abortions
8. The importance of STD-screening in the preconceptional care
9. Evaluation of counselling for pregnant women exposed to potentially hazardous environmental factors